State AR
Clinical Trials in Arkansas
Recruiting clinical trials with at least one study location in Arkansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arkansas
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05101551 Phase 1
Recruiting
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML ...
Condition
Acute Myeloid Leukemia
Enrollment
34 pts
Location
United States
Sponsor
Norman J. Lacayo
NCT05871970 Phase 2
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic...
Condition
Lymphatic Malformation
Enrollment
38 pts
Location
United States
Sponsor
Protara Therapeutics
NCT05947851 Phase 3
Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Secon...
Condition
Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment
735 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06621251 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosth...
Condition
Prosthetic Joint Infections of Hip
Enrollment
60 pts
Location
United States
Sponsor
Trellis Bioscience LLC
NCT05826665 N/A
Recruiting
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assist...
Condition
Persistent Atrial Fibrillation
Enrollment
200 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT05156983 Phase 3
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Nee...
Condition
Coagulation Disorder
Enrollment
328 pts
Location
United States, Argentina, Austria
Sponsor
Takeda
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT06055361 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single...
Condition
Atopic Dermatitis
Enrollment
45 pts
Location
United States
Sponsor
Brexogen Inc.
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05634369 Phase 1, Phase 2
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK...
Condition
Pediatric Sarcoma, Refractory
Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07343700 N/A
Recruiting
Community Expecting: Exercise During Pregnancy
Condition
Physical Activities
Enrollment
228 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT06462612 Phase 3
Recruiting
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
Condition
Bipolar Disorder, Manic
Enrollment
350 pts
Location
United States, Bulgaria, Romania
Sponsor
Intra-Cellular Therapies, Inc.
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania